Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations

Tenofovir, currently marketed as the prodrug tenofovir disoproxil fumarate, is used clinically to treat patients with HIV/AIDS. The oral bioavailability of tenofovir is relatively low, limiting its clinical effectiveness. Encapsulation of tenofovir within modified long-circulating liposomes would de...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Pharmacol
Main Authors: Spinks, Crystal B, Zidan, Ahmed S, Khan, Mansoor A, Habib, Muhammad J, Faustino, Patrick J
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2017
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5327912/
https://ncbi.nlm.nih.gov/pubmed/28260952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S119875
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki